Millennium Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.6M | Sell |
369,733
-2,990,465
| -89% | -$40.2M | ﹤0.01% | 3043 |
|
|
2025
Q4 | $42.3M | Buy |
3,360,198
+27,447
| +0.8% | +$314K | 0.02% | 924 |
|
|
2025
Q3 | $33.4M | Sell |
3,332,751
-1,710,276
| -34% | -$15.4M | 0.01% | 1168 |
|
|
2025
Q2 | $40.8M | Buy |
5,043,027
+2,955,629
| +142% | +$22.3M | 0.02% | 957 |
|
|
2025
Q1 | $17.5M | Buy |
2,087,398
+762,842
| +58% | +$6.37M | 0.01% | 1661 |
|
|
2024
Q4 | $10.5M | Buy |
1,324,556
+506,972
| +62% | +$4.25M | 0.01% | 2130 |
|
|
2024
Q3 | $6.8M | Sell |
817,584
-112,983
| -12% | -$884K | ﹤0.01% | 2559 |
|
|
2024
Q2 | $5.91M | Buy |
930,567
+442,932
| +91% | +$2.81M | ﹤0.01% | 2572 |
|
|
2024
Q1 | $2.96M | Buy |
+487,635
| New | +$2.75M | ﹤0.01% | 3385 |
|
|
2023
Q4 | – | Sell |
-732,146
| Closed | -$3.09M | – | 6038 |
|
|
2023
Q3 | $3.09M | Sell |
732,146
-296,495
| -29% | -$1.11M | ﹤0.01% | 3178 |
|
|
2023
Q2 | $3.19M | Sell |
1,028,641
-2,065,044
| -67% | -$4.4M | ﹤0.01% | 3080 |
|
|
2023
Q1 | $4.3M | Sell |
3,093,685
-1,919,693
| -38% | -$3.82M | ﹤0.01% | 2743 |
|
|
2022
Q4 | $9.98M | Buy |
5,013,378
+3,034,426
| +153% | +$6.8M | 0.01% | 2121 |
|
|
2022
Q3 | $4M | Buy |
1,978,952
+1,070,673
| +118% | +$3M | ﹤0.01% | 3124 |
|
|
2022
Q2 | $2.89M | Buy |
908,279
+772,235
| +568% | +$2.8M | ﹤0.01% | 3342 |
|
|
2022
Q1 | $567K | Sell |
136,044
-1,114,158
| -89% | -$4.93M | ﹤0.01% | 5026 |
|
|
2021
Q4 | $5.99M | Buy |
1,250,202
+372,898
| +43% | +$1.86M | ﹤0.01% | 2713 |
|
|
2021
Q3 | $4.68M | Buy |
877,304
+54,040
| +7% | +$272K | ﹤0.01% | 2941 |
|
|
2021
Q2 | $4.21M | Buy |
823,264
+565,132
| +219% | +$3.21M | ﹤0.01% | 2980 |
|
|
2021
Q1 | $1.74M | Buy |
+258,132
| New | +$1.43M | ﹤0.01% | 3662 |
|
|
2020
Q4 | – | Sell |
-70,093
| Closed | -$272 | – | 5167 |
|
|
2020
Q3 | $272 | Sell |
70,093
-48,504
| -41% | -$207K | ﹤0.01% | 3891 |
|
|
2020
Q2 | $565K | Buy |
+118,597
| New | +$488K | ﹤0.01% | 3330 |
|
|
2020
Q1 | – | Sell |
-1,719,817
| Closed | -$8.29M | – | 3800 |
|
|
2019
Q4 | $8.29M | Buy |
1,719,817
+971,365
| +130% | +$3.38M | 0.01% | 1534 |
|
|
2019
Q3 | $2.17M | Buy |
748,452
+128,515
| +21% | +$448K | ﹤0.01% | 2391 |
|
|
2019
Q2 | $4.45M | Buy |
619,937
+564,739
| +1,023% | +$5.77M | 0.01% | 1867 |
|
|
2019
Q1 | $782K | Buy |
+55,198
| New | +$730K | ﹤0.01% | 3010 |
|
|
2018
Q4 | – | Sell |
-140,567
| Closed | -$3.12M | – | 3715 |
|
|
2018
Q3 | $3.12M | Sell |
140,567
-1,551,688
| -92% | -$32.7M | ﹤0.01% | 2119 |
|
|
2018
Q2 | $27.8M | Buy |
+1,692,255
| New | +$29.7M | 0.04% | 685 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
Millennium Management's AMRX Position: Q1 2026 in Review
Millennium Management reduced its Amneal Pharmaceuticals (AMRX) stake by 89% in Q1 2026, selling an estimated $40.2M and leaving 369,733 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3043.
Millennium Management first reported a position in AMRX in Q2 2018 and has held it in 28 quarters since. The position peaked at $42.3M in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.
- Millennium Management held 369,733 shares of Amneal Pharmaceuticals worth $4.6M as of Q1 2026.
- Millennium Management sold 2,990,465 Amneal Pharmaceuticals shares in Q1 2026, an estimated $40.2M.
- Amneal Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3043 holding.
- Millennium Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 28 quarters since.
- Millennium Management's Amneal Pharmaceuticals position peaked at $42.3M in Q4 2025.
- 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.